GSK Funds NCCN To Support Oncology Research
The NCCN Oncology Research Program (ORP) facilitates all phases of clinical research by identifying clinical investigators and initiating trials at NCCN Member Institutions. GSK said that the ORP
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.
Upp Technology’s software selected from the suite includes IRMS|EM Emergency Management, IRMS|WM Warehouse Management and IRMS|BI Business Intelligence to provide the BSPS with real-time visibility, enhanced accuracy and
The collaboration will use Marina’s patented Trp Cage phage display library and Dr Laakkonen’s expertise with phage display libraries and experience in the evaluation of peptides for preferential